Target intelligence / Profile preview

Lipid peroxyl radical in membrane (LOO·)

Target
LOO·
Molecular classification
Other
01

Overview

Lipid peroxyl radicals (LOO·) are short-lived, highly reactive intermediates produced during the propagation phase of lipid peroxidation in biological membranes. They arise when polyunsaturated fatty acid (PUFA) residues in phospholipids are attacked by reactive oxygen species, forming a lipid radical (L·) that rapidly reacts with molecular oxygen to yield a peroxyl radical (LOO·). These radicals propagate membrane lipid peroxidation chain reactions, resulting in structural and functional damage to cell membranes, and are implicated in various pathological processes including ferroptosis and regulated forms of cell death associated with neurodegenerative, cardiovascular, and inflammatory diseases. Lipid peroxyl radicals themselves are not considered conventional drug targets (e.g. receptors, enzymes), but mitigating their formation or effects via antioxidants (like vitamin E or melatonin) is a therapeutic strategy. Laboratory measurement of lipid peroxidation typically involves detection of downstream stable products such as malondialdehyde (MDA) or 4-hydroxynonenal (4-HNE). Clarification: "Lipid peroxyl radicals in membranes" is not a receptor, enzyme, or protein, but a reactive chemical species central to a pathological process (lipid peroxidation) and is not a classic therapeutic target itself. If you are seeking information on a specific enzyme that generates or removes lipid peroxyl radicals (e.g., Lipoxygenase, Glutathione peroxidase 4/GPX4, or Cytochrome P450 enzymes), please clarify the exact target.

Other names
Lipid hydroperoxyl radicalLOO·peroxyl radical
02

Mechanism of action

Scavenging of peroxyl radicals to interrupt the lipid peroxidation chain reaction

03

Biological functions

Cell death (including ferroptosis, necrosis)Membrane damage/oxidative stress propagation
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseInflammationCancer
05

Safety considerations

Lipid peroxyl radicals are not a therapeutic target themselves; they are highly reactive intermediates with fleeting existence. There is no direct therapeutic modulation.Safety concerns relate to off-target effects of antioxidant drugs and generalized oxidative stress responses.
06

Interacting drugs

Antioxidants (for example: vitamin E/tocopherol, melatonin)
07

Biomarkers

Lipid peroxidation end products: malondialdehyde (MDA)4-hydroxynonenal (4-HNE)isoprostanes

Beyond the preview

Go deeper on Lipid peroxyl radical in membrane (LOO·).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid peroxyl radical in membrane (LOO·).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call